We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Boston Scientific

Boston Scientific is a biomedical/biotechnology engineering company and multinational manufacturer of medical devices... read more Featured Products: More products

Download Mobile App




Next-Gen Insertable Cardiac Monitor Offers Long-Term Monitoring for Arrhythmias

By HospiMedica International staff writers
Posted on 04 Oct 2023
Print article
Image: The LUX-Dx II+ Insertable Cardiac Monitor (ICM) System (Photo courtesy of Boston Scientific)
Image: The LUX-Dx II+ Insertable Cardiac Monitor (ICM) System (Photo courtesy of Boston Scientific)

A next-generation insertable cardiac monitor (ICM) uses enhanced detection algorithms for long-term monitoring of arrhythmias associated with conditions like atrial fibrillation (AF), cryptogenic stroke, and syncope.

Boston Scientific (Marlborough, MA, USA) has launched the LUX-Dx II+ ICM System which features two-stage algorithms to first identify and then confirm potential arrhythmias before sending an alert to healthcare providers. This ensures that the data clinicians receive is both reliable and useful for making treatment decisions. What's more, the device offers remote programming, allowing doctors and healthcare teams to modify detection settings and track symptoms without requiring a face-to-face consultation with the patient.

The dual-stage algorithms in the LUX-Dx II+ ICM System can be configured to spot various types of heart irregularities such as AF, atrial and ventricular tachycardia, bradycardia, and episodes of rhythm pause. These algorithms include a newly added feature for premature ventricular contraction (PVC) burden, designed to recognize arrhythmias whenever preset limits or guidelines are surpassed. The system also employs additional verification filters, including specific settings for nighttime that focus on bradycardia and pause incidents, aiming to eliminate false positives and irrelevant episodes. For enhanced patient experience, the system also offers a new app for easier and more streamlined remote monitoring.

“The LUX-Dx II+ ICM System builds on a strong foundation of cardiac diagnostic technologies at Boston Scientific to provide care teams with the necessary data for critical decision making,” said Scott Olson, senior vice president and president, Cardiac Rhythm Management and Diagnostics, Boston Scientific. “With enhanced and new diagnostic algorithms, physicians will receive timely, accurate and actionable insights to help them make clinically meaningful decisions.”

Related Links:
Boston Scientific

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Digital X-Ray Detector Panel
Acuity G4
Medical Monitor
VITALMAX 4100SL

Print article

Channels

Surgical Techniques

view channel
Image: Miniaturized electric generators based on hydrogels for use in biomedical devices (Photo courtesy of HKU)

Hydrogel-Based Miniaturized Electric Generators to Power Biomedical Devices

The development of engineered devices that can harvest and convert the mechanical motion of the human body into electricity is essential for powering bioelectronic devices. This mechanoelectrical energy... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.